Clinical Trial Update: Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating umbilical cord–derived mesenchymal stem cell transplantation in children with biliary atresia; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia
• Biliary Cholangitis

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Primary Biliary Cirrhosis | Phase 1, Phase 2 | Status: COMPLETED